Peptides & Elephants GMBH

UEI
ULG6HL3KDN14
CAGE
CL151
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Other
SAM.gov registration date
Website
peptides.de
Founded
2001
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 -$15,265

Contract awards

Award Agency Obligated Awarded
Purchase of synthetic peptides, peptide pool generation, external analytics, endotoxin testing, providing manufacturing… HHSN261201800145P National Cancer Institute (NIH) $4,935
Peptides & elephants gmbh/lab supplies/cafri HHSN261201800032P National Cancer Institute (NIH) $7,675

Quick answers

Is Peptides & Elephants GMBH registered in SAM.gov?

Peptides & Elephants GMBH's SAM.gov registration expired on June 18, 2025.

What is Peptides & Elephants GMBH's most recent federal award?

Peptides & Elephants GMBH's most recent federal contract award is Purchase of synthetic peptides, peptide pool generation, external analytics, endotoxin testing, providing manufacturing… (HHSN261201800145P), from National Cancer Institute (NIH), on January 30, 2018.

On GovTribe

See Peptides & Elephants GMBH's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login